391 related articles for article (PubMed ID: 18555604)
1. Pramipexole has astrocyte-mediated neuroprotective effects against lactacystin toxicity.
Imamura K; Takeshima T; Nakaso K; Ito S; Nakashima K
Neurosci Lett; 2008 Aug; 440(2):97-102. PubMed ID: 18555604
[TBL] [Abstract][Full Text] [Related]
2. Involvement of dopamine D(2)/D(3) receptors and BDNF in the neuroprotective effects of S32504 and pramipexole against 1-methyl-4-phenylpyridinium in terminally differentiated SH-SY5Y cells.
Presgraves SP; Borwege S; Millan MJ; Joyce JN
Exp Neurol; 2004 Nov; 190(1):157-70. PubMed ID: 15473989
[TBL] [Abstract][Full Text] [Related]
3. Dopamine D3 receptor-preferring agonists induce neurotrophic effects on mesencephalic dopamine neurons.
Du F; Li R; Huang Y; Li X; Le W
Eur J Neurosci; 2005 Nov; 22(10):2422-30. PubMed ID: 16307585
[TBL] [Abstract][Full Text] [Related]
4. Both the antioxidant and D3 agonist actions of pramipexole mediate its neuroprotective actions in mesencephalic cultures.
Ling ZD; Robie HC; Tong CW; Carvey PM
J Pharmacol Exp Ther; 1999 Apr; 289(1):202-10. PubMed ID: 10087005
[TBL] [Abstract][Full Text] [Related]
5. Continuous subcutaneous infusion of pramipexole protects against lipopolysaccharide-induced dopaminergic cell death without affecting the inflammatory response.
Iravani MM; Sadeghian M; Leung CC; Tel BC; Rose S; Schapira AH; Jenner P
Exp Neurol; 2008 Aug; 212(2):522-31. PubMed ID: 18571649
[TBL] [Abstract][Full Text] [Related]
6. Pitx3-transfected astrocytes secrete brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor and protect dopamine neurons in mesencephalon cultures.
Yang D; Peng C; Li X; Fan X; Li L; Ming M; Chen S; Le W
J Neurosci Res; 2008 Nov; 86(15):3393-400. PubMed ID: 18646205
[TBL] [Abstract][Full Text] [Related]
7. Distinct effects of pramipexole on the proliferation of adult mouse sub-ventricular zone-derived cells and the appearance of a neuronal phenotype.
Merlo S; Canonico PL; Sortino MA
Neuropharmacology; 2011 May; 60(6):892-900. PubMed ID: 21272591
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective effect of the antiparkinsonian drug pramipexole against nigrostriatal dopaminergic degeneration in rotenone-treated mice.
Inden M; Kitamura Y; Tamaki A; Yanagida T; Shibaike T; Yamamoto A; Takata K; Yasui H; Taira T; Ariga H; Taniguchi T
Neurochem Int; 2009 Dec; 55(8):760-7. PubMed ID: 19647776
[TBL] [Abstract][Full Text] [Related]
9. Novel neuroprotective mechanisms of pramipexole, an anti-Parkinson drug, against endogenous dopamine-mediated excitotoxicity.
Izumi Y; Sawada H; Yamamoto N; Kume T; Katsuki H; Shimohama S; Akaike A
Eur J Pharmacol; 2007 Feb; 557(2-3):132-40. PubMed ID: 17161393
[TBL] [Abstract][Full Text] [Related]
10. Protective role of heat shock and heat shock protein 70 in lactacystin-induced cell death both in the rat substantia nigra and PC12 cells.
Ahn TB; Jeon BS
Brain Res; 2006 May; 1087(1):159-67. PubMed ID: 16626658
[TBL] [Abstract][Full Text] [Related]
11. The effect of dopamine agonists: the expression of GDNF, NGF, and BDNF in cultured mouse astrocytes.
Ohta K; Kuno S; Inoue S; Ikeda E; Fujinami A; Ohta M
J Neurol Sci; 2010 Apr; 291(1-2):12-6. PubMed ID: 20129627
[TBL] [Abstract][Full Text] [Related]
12. Apomorphine-induced activation of dopamine receptors modulates FGF-2 expression in astrocytic cultures and promotes survival of dopaminergic neurons.
Li A; Guo H; Luo X; Sheng J; Yang S; Yin Y; Zhou J; Zhou J
FASEB J; 2006 Jun; 20(8):1263-5. PubMed ID: 16636101
[TBL] [Abstract][Full Text] [Related]
13. Nurr1 deficiency predisposes to lactacystin-induced dopaminergic neuron injury in vitro and in vivo.
Pan T; Zhu W; Zhao H; Deng H; Xie W; Jankovic J; Le W
Brain Res; 2008 Jul; 1222():222-9. PubMed ID: 18579122
[TBL] [Abstract][Full Text] [Related]
14. Protection of ischemic brain cells is dependent on astrocyte-derived growth factors and their receptors.
Lin CH; Cheng FC; Lu YZ; Chu LF; Wang CH; Hsueh CM
Exp Neurol; 2006 Sep; 201(1):225-33. PubMed ID: 16765947
[TBL] [Abstract][Full Text] [Related]
15. Bromocriptine protects dopaminergic neurons from levodopa-induced toxicity by stimulating D(2)receptors.
Takashima H; Tsujihata M; Kishikawa M; Freed WJ
Exp Neurol; 1999 Sep; 159(1):98-104. PubMed ID: 10486178
[TBL] [Abstract][Full Text] [Related]
16. Protein from chromaffin granules promotes survival of mesencephalic dopaminergic neurons by an EGF-receptor ligand-mediated mechanism.
Krieglstein K; Unsicker K
J Neurosci Res; 1997 Apr; 48(1):18-30. PubMed ID: 9086178
[TBL] [Abstract][Full Text] [Related]
17. Novel D3 dopamine receptor-preferring agonist D-264: Evidence of neuroprotective property in Parkinson's disease animal models induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and lactacystin.
Li C; Biswas S; Li X; Dutta AK; Le W
J Neurosci Res; 2010 Aug; 88(11):2513-23. PubMed ID: 20623619
[TBL] [Abstract][Full Text] [Related]
18. Human dental pulp stem cells protect mouse dopaminergic neurons against MPP+ or rotenone.
Nesti C; Pardini C; Barachini S; D'Alessandro D; Siciliano G; Murri L; Petrini M; Vaglini F
Brain Res; 2011 Jan; 1367():94-102. PubMed ID: 20854799
[TBL] [Abstract][Full Text] [Related]
19. Standardized methods to bioassay neurotrophic factors for dopaminergic neurons.
Takeshima T; Shimoda K; Johnston JM; Commissiong JW
J Neurosci Methods; 1996 Jul; 67(1):27-41. PubMed ID: 8844522
[TBL] [Abstract][Full Text] [Related]
20. Pramipexole protects against MPTP toxicity in non-human primates.
Iravani MM; Haddon CO; Cooper JM; Jenner P; Schapira AH
J Neurochem; 2006 Mar; 96(5):1315-21. PubMed ID: 16464239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
